📰 Remote Data Acquisition News
Page 3 - Remote Data Acquisition News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Remote Data Acquisition. Real-time updates on events, politics, business and more.
July 11, 2022
/PRNewswire/ -- The Global Clinical Trials Connect 2022 conference has been added to ResearchAndMarkets.coms offering. The Global Clinical Trials Connect...
June 23, 2022
Dublin, June 23, 2022 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Connect 2022" conference has been added to ResearchAndMarkets.com's offering. The...
May 2, 2022
05/02/22 Life Science Leader Newsletter
March 11, 2022
In December 2021, FDA issued draft guidance, Digital Health Technologies (DHTs) for Remote Data Acquisition in Clinical Investigations, which provides guidance for clinical trial...
March 9, 2022
Note From the Editors With 2022 well underway, the rapid pace of statutory, regulatory, policy, and industry activities in digital health continues in force. We bring you Vital Signs, a...
February 23, 2022
In this white paper, learn more about the new draft guidance on Digital Health Technologies (DHTs) for Remote Data Acquisition in Clinical...
February 21, 2022
In response to COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) continues to work in support of clinical investigation sponsors and an evolving environment in which they run their clinical trials...
February 18, 2022
In response to COVID-19 pandemic, the U.S. Food and Drug Administration (FDA) continues to work in support of clinical investigation sponsors and an evolving environment in which they...
January 6, 2022
It is the beginning of January again. During this time of year we typically publish a series of blog posts that recap the most interesting Food and Drug Administration FDA activities over the prior 12 months and consider what the agency is likely to focus on going forward.
January 6, 2022
It is, somewhat amazingly, the beginning of January again. During this time of year we typically publish a series of blog posts that recap the most interesting Food and Drug...